Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 3091 AL 3105

Long-Lasting Neuropsychological Effects of a Computerized Cognitive Training in Patients Affected by Early Stage Alzheimer's Disease: Are They Stable Over Time?

Cavallo M, Angilletta C.

J Appl Gerontol. 2019 Jul;38(7):1035-1044. doi: 10.1177/0733464817750276. Epub 2018 Jan 2.

Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials

Atri A, Frölich L, Ballard C, Tariot PN, Molinuevo JL, Boneva N, Windfeld K, Raket LL, Cummings JL.

JAMA. 2018 Jan 9;319(2):130-142. doi: 10.1001/jama.2017.20373.

Similar treatment outcomes with Ginkgo biloba extract EGb 761 and donepezil in Alzheimer's dementia in very old age: A retrospective observational study

Rapp M, Burkart M, Kohlmann T, Bohlken J.

Int J Clin Pharmacol Ther. 2018 Mar;56(3):130-133. doi: 10.5414/CP203103.

News on the journal Neurological Sciences in 2017

Di Donato I, Federico A.

Neurol Sci. 2018 Jan;39(1):15-21. doi: 10.1007/s10072-017-3241-x.

Cultural Competency in Dementia Care: An African American Case Study

Clark JL, Phoenix S, Bilbrey AC, McManis T, Escal KA, Arulanantham R, Sisay T, Ghatak R.

Clin Gerontol. 2018 May-Jun;41(3):255-260. doi: 10.1080/07317115.2017.1420725. Epub 2018 Jan 17.

The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial

Scherer RW, Drye L, Mintzer J, Lanctôt K, Rosenberg P, Herrmann N, Padala P, Brawman-Mintzer O, Burke W, Craft S, Lerner AJ, Levey A, Porsteinsson A, van Dyck CH; ADMET 2 Research Group.

Trials. 2018 Jan 18;19(1):46. doi: 10.1186/s13063-017-2406-5.

Emergency Department Use by Community-Dwelling Individuals With Dementia in the United States: An Integrative Review

Hunt LJ, Coombs LA, Stephens CE.

J Gerontol Nurs. 2018 Mar 1;44(3):23-30. doi: 10.3928/00989134-20171206-01. Epub 2018 Jan 23.

From Research to Application: Supportive and Therapeutic Environments for People Living With Dementia

Calkins MP.

Gerontologist. 2018 Jan 18;58(suppl_1):S114-S128. doi: 10.1093/geront/gnx146.

Meeting the Informational, Educational, and Psychosocial Support Needs of Persons Living With Dementia and Their Family Caregivers

Whitlatch CJ, Orsulic-Jeras S.

Gerontologist. 2018 Jan 18;58(suppl_1):S58-S73. doi: 10.1093/geront/gnx162.

Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease

Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M, Hager K, Andreasen N, Scarpini E, Liu-Seifert H, Case M, Dean RA, Hake A, Sundell K, Poole Hoffmann V, Carlson C, Khanna R, Mintun M, DeMattos R, Selzler KJ, Siemers E.

N Engl J Med. 2018 Jan 25;378(4):321-330. doi: 10.1056/NEJMoa1705971.

Data-driven identification of endophenotypes of Alzheimer's disease progression: implications for clinical trials and therapeutic interventions

Geifman N, Kennedy RE, Schneider LS, Buchan I, Brinton RD.

Alzheimers Res Ther. 2018 Jan 15;10(1):4. doi: 10.1186/s13195-017-0332-0.

Research progress of epigenetic biomarkers in the early diagnosis and treatment of human diseases

Li W, Qin J, Wang H, Chen LB.

Yi Chuan. 2018 Feb 20;40(2):104-115. doi: 10.16288/j.yczz.17-220.

Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab

Liu E, Wang D, Sperling R, Salloway S, Fox NC, Blennow K, Scheltens P, Schmidt ME, Streffer J, Novak G, Einstein S, Booth K, Ketter N, Brashear HR; ELN115727-301/302 Investigator Group.

Neurology. 2018 Mar 6;90(10):e877-e886. doi: 10.1212/WNL.0000000000005060. Epub 2018 Feb 2.

The Global Music Approach to Dementia (GMA-D): evidences from a case report

Raglio A, Filippi S, Leonardelli L, Trentini E, Bellandi D.

Aging Clin Exp Res. 2018 Dec;30(12):1533-1536. doi: 10.1007/s40520-018-0919-8. Epub 2018 Feb 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias